(Update1) High Court’s ruling on so-called ‘partial institutions’ of IPRs seen benefiting petitioners and patent holders

The U.S. Supreme Court’s decision in SAS v. Iancu, which rejects partial institution decisions on inter partes reviews,  is far more momentous than the high court's decision in Oil States v. Greene Energy, which affirmed the constitutionality of the IPR process, because SAS revises existing practices while Oil States reinforces the status quo. In SAS [...]

By | April 24th, 2018|Patent Investing, PTAB, Supreme Court, USPTO|0 Comments

(Update1) Fortress unit has filed liens on patents assigned to Theranos IP Co. LLC

Fortress Investment Group (FIG) may be about to take over patents assigned to Theranos IP Co. LLC, a unit of Theranos Inc., the troubled medical device company whose former CEO Elizabeth Holmes settled a fraud complaint filed by the Securities and Exchange Commission, based on liens placed on the patents by Fortress Credit Corp. New [...]

By | April 10th, 2018|Patent Investing, USPTO|0 Comments

Federal Circuit reverses PTAB decision invalidating DSS patent enforced against Apple

Document Security Systems Inc. (DSS), the patent licensing company run by CEO Jeff Ronaldi, said it won reversal of a Patent Trial and Appeal Board decision that found that claims of a patent being enforced against Apple were unpatentable. Rochester, New York-based DSS said U.S. Patent No. 6,128,290 is the subject of DSS's patent infringement [...]

Reps. Stivers and Foster to introduce patent-owner friendly STRONGER Patent Act in the House

Representatives Steve Stivers (a Republican from Ohio) and Bill Foster (a Democrat from Illinois) are expected to introduce the House version of last year’s Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act, which was introduced in the Senate Even before it was introduced in the House the bill had [...]

Biogen MA sues USPTO Director for extra 23 days in term of human anti-tau antibodies patent

What is 23 days worth to you? Pharmaceutical giant Biogen MA is suing Andrei Iancu, the director of the U.S. Patent and Trademark Office, to force the PTO to extend a patent for Human Anti-Tau Antibodies for an extra 23 days because of an alleged improper calculation of delays in the approval of the patent. [...]

By | February 15th, 2018|drug patents, litigation, Patent Investing, USPTO|0 Comments

St. Regis Mohawk Tribe “is going to war” with the PTAB over concerns about its impartiality

The St. Regis Mohawk Tribe, which is trying to use its sovereign immunity to shield patents it acquired from Allergan Plc from review by the patent Trial and Appeal Board, “is going to war with the PTAB,” according to Michael Shore, a partner at Shore Chan Depumpo, who is one of the lawyers who dreamed [...]

By | January 4th, 2018|Patent Investing, PTAB, USPTO|0 Comments

Saint Regis Mohawk Tribe defends its Allergan deal in reply to opposition to dismiss IPRs

The Saint Regis Mohawk Tribe defended the controversial transaction in which Allergan Plc assigned patents for the chronic dry eye drug Restasis to the tribe for a promise to use its tribal immunity as a shield against inter partes review challenges before the Patent Trial and Appeal Board. The defense came in the form of [...]

Finjan leads all public IP licensing companies in successful defense of IPRs, Patexia says

Finjan Holdings Inc. (FNJN), the cybersecurity technology and licensing company run by CEO Phil Hartstein, leads all publicly traded patent licensing companies in defending against inter partes review challenges of its patents, according to Patexia, a global community network for intellectual property professionals. East Palo Alto, California-based Finjan has won 87% or 32 of the [...]

By | September 13th, 2017|Patent Investing, PTAB, USPTO|0 Comments

President Trump nominates Irell & Manella’s Andrei Iancu as Director of the USPTO

President Donald Trump as expected said he intends to nominate Andrei Iancu, the managing partner with the law firm of Irell & Manella LP, to be Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office, Department of Commerce. Iancu has advised plaintiffs and defendants across a wide variety [...]

By | August 31st, 2017|exec changes, Patent Investing, USPTO|0 Comments

Google and other tech giants unveil the High Tech Inventors Alliance to work toward a “balanced” U.S. patent system

Adobe, Amazon, Cisco, Dell, Google, Intel, Oracle and Salesforce, who invested $62.9 billion in research and development in 2016, collectively own more than 115,000 patents and employ more than 447,000 in the U.S, have joined together to form the High Tech Inventors Alliance (HTIA), dedicated to supporting “balanced patent policy.” The alliance’s focus on a balanced patent system [...]